FZD7 and gastric cancer: However, in colorectal and gastric cancers, FZD7 is overexpressed, amplifying β-catenin signaling to sustain tumor growth and resistance to therapy (Phesse et al., 2016; Li et al., 2018; Ye et al., 2019).